Skip to content

A clinical study to understand the benefit of two products that is multi-berry gel and tetracycline fibers in the treatment of pyorrhoea patients as a site specific delivery in the gums.

Evaluating the effectiveness of local drug delivery of Multi-berry gel and Tetracycline fibers for the management of periodontitis patients: A randomized control study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082127
Enrollment
50
Registered
2025-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Multi-berry gel ( Cranberry and Garcinia Cambogia ): Cranberry is a superfruit in many countries including India. The development of two bacterial species, Porphyromonas gingivalis and

Sponsors

Dr Sakshi Romil Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Systemically healthy patients of both sexes between 30 and 65 years. 2. Having at minimum two teeth with one proximal site with (clinical attachment level [CAL] of 3-4mm, and (probing pocket depth [PPD] of 5-7mm) - stage II/III.

Exclusion criteria

Exclusion criteria: 1.Previous use of systemic or local antibiotic, anti-inflammatory drugs or periodontal therapy in the previous 6 months. 2.Allergic to tetracycline, cranberry and garcinia cambogia 3.Smokers 4.Pregnant/lactating woman . 5.Patients on any medication for systemic diseases like diabetes and hypertension etc.

Design outcomes

Primary

MeasureTime frame
Pocket probing depth, Clinical Attachment LevelTimepoint: Baseline, 1 month and 3 months

Secondary

MeasureTime frame
Sulcus Bleeding Index and Quigley and Hein s plaque index as modified by Turesky et al.Timepoint: Baseline, 1 month and 3 months

Countries

India

Contacts

Public ContactDr Jasuma Rai

KM Shah Dental College and Hospital

drjasumaj@gmail.com9974005760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026